Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Nov 16, 2021; 9(32): 9825-9834
Published online Nov 16, 2021. doi: 10.12998/wjcc.v9.i32.9825
Table 4 The progression-free survival times of patients with different systemic immune inflammation index, ratio of lymphocytes to monocytes and ratio of lymphocytes to monocytes to lactate dehydrogenase expression
Groups
Median progression free survival time
95%CI
χ2
P value
SII high expression34 mo32.52-38.507.7420.222
SII low expression42 mo39.50-46.16
LMR high expression35 mo33.42-36.588.3560.004
LMR low expression43 mo40.64-45.36
LMR/LDH high expression35 mo33.49-36.5115.1630.000
LMR/LDH low expression43 mo40.73-45.27